YAKUODO HOLDINGS Co., Ltd. (TYO:7679)
Japan · Delayed Price · Currency is JPY 2,260.00
+9.00 (0.40%)
Jul 18, 2025, 3:30 PM JST
YAKUODO HOLDINGS Revenue
YAKUODO HOLDINGS had revenue of 39.41B JPY in the quarter ending May 31, 2025, with 7.60% growth. This brings the company's revenue in the last twelve months to 154.74B, up 6.65% year-over-year. In the fiscal year ending February 28, 2025, YAKUODO HOLDINGS had annual revenue of 151.96B with 6.83% growth.
Revenue (ttm)
154.74B
Revenue Growth
+6.65%
P/S Ratio
0.29
Revenue / Employee
154.74M
Employees
1,000
Market Cap
44.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 151.96B | 9.72B | 6.83% |
| Feb 29, 2024 | 142.24B | 13.45B | 10.44% |
| Feb 28, 2023 | 128.79B | 8.48B | 7.05% |
| Feb 28, 2022 | 120.31B | 9.78B | 8.84% |
| Feb 28, 2021 | 110.54B | 8.52B | 8.35% |
| Feb 29, 2020 | Pro | Pro | Pro |
| Feb 28, 2019 | Pro | Pro | Pro |
| Feb 29, 2012 | Pro | Pro | Pro |
| Feb 28, 2011 | Pro | Pro | Pro |
| Feb 28, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |